U.S. Department of Health and Human Services
Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Brief Version (N/A)
Financial Disclosure
Last Updated: November 14, 2017; Last Reviewed: November 14, 2017
| Name | Panel Status | Company | Relationship |
|---|---|---|---|
| Aaron, Erika |
M | Gilead | Research Support |
| Abrams, Elaine J. | M | ViiV | Advisory Board |
| Anderson, Jean | M | Gilead | Stockholder |
| Best, Brookie M. | M | PPD | DSMB |
| C&R Research, Inc. | DSMB | ||
| Brown, Gina | HHS | None | N/A |
| Chakhtoura, Nahida | HHS | None | N/A |
| Chakraborty, Rana |
M | Gilead |
Research Support |
| Ciaranello, Andrea | M | None | N/A |
| Cohn, Susan E. |
M | Eli Lilly and Company |
Stockholder |
| Cu-Uvin, Susan |
M | AIDS Malignancy Consortium | DSMB |
| Gilead | Advisory Board | ||
| Deyo, Stephanie | M | None | N/A |
| Diouf, Khady | M | None | N/A |
| Feinberg, Judith |
M | BMS | Advisory Board |
| Gilead | Research Support | ||
| ViiV | Advisory Board | ||
| Flynn, Patricia M. | M | Merck |
DSMB Member |
| Jao, Jennifer | M | None | N/a |
| Kakkar, Fatima | ExOM | None | N/A |
| Kourtis, Athena, P. | HHS | None | N/A |
| Lazenby, Gweneth B. |
M | None | N/A |
| Levison, Judy | M | None | N/A |
| Maupin, Robert T. |
M | None | N/A |
| Minkoff, Howard | M | None | N/A |
| Mirochnick, Mark | CC | ViiV | DSMB |
| Merck | DSMB | ||
| Mofenson, Lynne M. |
M | None | N/A |
| Momplaisir, Florance | M | None | N/A |
| Nesheim, Steve | HHS | None | N/A |
| Pollock, Lealah | ExOM | None | N/A |
| Prioleau, Fatima Y. | M | None | N/A |
| Rahangdale, Lisa | M | None | N/A |
| Siberry, George K. | ES | None | N/A |
| Sissoho, Fatoumatta | M | None | N/A |
| Spector, Stephen A. | M | None | N/A |
| Squires, Kathleen E. |
M | Bristol Myers Squibb | Advisory Board |
| Gilead |
Advisory Board Research Support |
||
| Janssen |
Advisory Board | ||
| Merck | Advisory Board | ||
| ViiV | Advisory Board | ||
| Storm, Deborah |
NVO | Merck | Stockholder |
| Eli Lilly and Company | Stockholder | ||
| Roche | Stockholder | ||
| Tuomala, Ruth | M | None | N/A |
| Viswanathan, Prabha | HHS | None | N/A |
| Watts, D. Heather | HHS | None | N/A |
| Wright, Rodney | M | None | N/A |
| Key to Acronyms: DSMB = Data Safety Monitoring Board; CC = Panel Co-Chairs; ES = Executive Secretary; ExOM = Ex Officio Member; HHS = Member from Department of Health and Human Services; M = Member; N/A = Not applicable; NVO = Nonvoting Observer | |||
Download Guidelines
- Section Only PDF (179 KB)
- Full Guideline PDF ()
- Recommendations Only PDF (473 KB)
- Tables Only PDF (1.7 MB)
Email Updates
